Stocks
Arena Pharmaceuticals (ARNA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -11.5 | -11.1 | 3.21 | -7.95 | -7.53 | -8.63 | ||
| Changes by years, y/y, % | -76% | -4% | -129% | -347% | -5% | -31.0% | |||
Arena Pharmaceuticals. EV/EBITDA
Arena Pharmaceuticals. EV/EBITDA, changes, %
Arena Pharmaceuticals (ARNA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | LTM ? | |||
| EV/EBITDA | ? | -8.42 | -7.39 | -6.75 | -5.06 | -8.52 | -8.63 | |
| Changes by years, y/y, % | -362% | +87% | +11% | -40% | +1% | |||
| Changes by quarters, q/q, % | 0% | -12% | -9% | -25% | +69% | |||
